Insight Molecular Diagnostics IMDX
NASDAQ IMDX
$4.27 -0.03 (-0.70%)
As of: Aug 27, 2026 · 3:59 PM EDT

Insight Molecular Diagnostics (IMDX) Current Taxes (2015 - 2016)

Insight Molecular Diagnostics (IMDX) posted Current Taxes of $151000.0 for Q4 2016, little changed sequentially from $151000.0 in Q3 2016, and up 277.5% YoY from $40000.0 in Q1 2016.

Insight Molecular Diagnostics (IMDX) Current Taxes (2015 - 2016) Analysis & Trends

Insight Molecular Diagnostics has reported Current Taxes for 2 years, with the latest figure at $151000.0 in Q4 2016.

  • Quarterly Current Taxes rose 277.5% year-over-year to $151000.0 in Q4 2016, while the trailing twelve-month figure through Dec 2016 was $151000.0 (up 277.5% YoY) and the FY2016 annual result came in at $151000.0, up 277.5% from the prior year.
  • Current Taxes held at $151000.0 in Q4 2016 per IMDX's latest filing, from $151000.0 in the prior quarter.
  • Over five years, Current Taxes peaked at $151000.0 in Q2 2016 and troughed at $40000.0 in Q4 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn -
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn -
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn -
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn -
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn 175.00 Mn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn -
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 188.49 Mn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn -
10 Insight Molecular Diagnostics 158.03 Mn 139.50 Mn 157,000.00 -

Historic Data

Download Data
DateValue
Dec 31, 2016 151,000.00
Sep 30, 2016 151,000.00
Jun 30, 2016 151,000.00
Dec 31, 2015 40,000.00